A475960 Stock Overview
Engages in the manufacture and sale of optical devices and medical equipment. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Tomocube, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩11,980.00 |
52 Week High | ₩15,750.00 |
52 Week Low | ₩9,930.00 |
Beta | 0 |
11 Month Change | n/a |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 18.97% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
A475960 | KR Medical Equipment | KR Market | |
---|---|---|---|
7D | 7.7% | 9.4% | 2.3% |
1Y | n/a | 12.3% | -3.8% |
Return vs Industry: Insufficient data to determine how A475960 performed against the KR Medical Equipment industry.
Return vs Market: Insufficient data to determine how A475960 performed against the KR Market.
Price Volatility
A475960 volatility | |
---|---|
A475960 Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 7.0% |
Market Average Movement | 5.7% |
10% most volatile stocks in KR Market | 11.4% |
10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A475960's share price has been volatile over the past 3 months compared to the KR market.
Volatility Over Time: Insufficient data to determine A475960's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2015 | n/a | Paul Yongkeun | www.tomocube.com |
Tomocube, Inc. engages in the manufacture and sale of optical devices and medical equipment. Its holotomography (HT) products include HT-X1 for live-cell imaging and analysis; and HT-2H for 3D live cell imaging. The company also offers TomoAnalysis, a 3D image visualization and analysis software.
Tomocube, Inc. Fundamentals Summary
A475960 fundamental statistics | |
---|---|
Market cap | ₩152.52b |
Earnings (TTM) | -₩22.70b |
Revenue (TTM) | ₩5.10b |
29.9x
P/S Ratio-6.7x
P/E RatioIs A475960 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A475960 income statement (TTM) | |
---|---|
Revenue | ₩5.10b |
Cost of Revenue | ₩2.12b |
Gross Profit | ₩2.97b |
Other Expenses | ₩25.67b |
Earnings | -₩22.70b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -1.78k |
Gross Margin | 58.35% |
Net Profit Margin | -445.48% |
Debt/Equity Ratio | 6.1% |
How did A475960 perform over the long term?
See historical performance and comparison